ACTRIMS 2025: Anticipating New Directions in DMTs for RRMS 🔗 Access full article via Medscape NeurologyDr Annalisa Morgan previews discussions on disease-modifying therapies, emerging treatments such as CAR T-cell therapy, and the challenges of managing MS in older patients. Medscape Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
